Clinical interpretation of immunoglobulin measurements requires accurate and precise assays and widely accepted reference preparations, as well as reliable age- and gender-specific reference ranges. This last requirement, the topic of numerous publications, has not been addressed adequately. By a co
Reference distributions for α2-macroglobulin: A comparison of a large cohort to the world's literature
✍ Scribed by Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 79 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The lack of satisfactory methods for quantifying serum levels and a credible reference material has limited bedside use of serum alpha~2~‐macroglobulin (α2M) measurements. Great strides have been made in the last few years. The remaining barrier to more relevant and cost effective use of serum protein data for diagnosis and prognosis is the availability of reliable reference intervals from birth to old age for both males and females. A total of 40 publications reporting reference intervals have been identified that meet the criteria used in our prior five studies, and these have been analyzed statistically. On average, previous small studies of these individual proteins agree with our life‐long reference ranges over their constrained age ranges. This meta‐analysis provides support for our reference ranges and places them in the perspective of previous publications. J. Clin. Lab. Anal. 18:148–152, 2004. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The appropriate clinical use of serum iron and transferrin saturation (TSAT) requires satisfactory reference intervals from birth to old age, and for males and females. This study identified 54 publications from 1974 to 2001 that met the criteria used in three prior meta‐analyses, and t
## Abstract The lack of credible reference materials and satisfactory methods for quantifying serum levels has limited the bedside use of complement protein (C3 and C4) measurements. However, great technological strides have been made in the last few years. The remaining barrier to a more relevant
## Abstract Limiting the clinical utility of apolipoproteins AI (apo AI) and B (apo B) and the apo B/AI ratios until the last decade has been the lack of satisfactory methods for quantifying serum levels and credible reference materials. Great technological strides have been made in the last few ye
Clinical interpretation of the acute-phase proteins-albumin, transferrin, and transthyretin-has been hampered by the lack of accurate and precise methods for quantifying the levels and a stable and respected reference material. Now that these issues have been addressed, the community is faced with t